Five preventable causes of kidney graft loss in the 1990s: A single-center analysis

被引:111
作者
Matas, AJ [1 ]
Humar, A [1 ]
Gillingham, KJ [1 ]
Payne, WD [1 ]
Gruessner, RWG [1 ]
Kandaswamy, R [1 ]
Dunn, DL [1 ]
Najarian, JS [1 ]
Sutherland, DER [1 ]
机构
[1] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA
关键词
organ rejection; kidney graft; allograft; transplantation; thrombosis; delayed graft function; chronic rejection;
D O I
10.1046/j.1523-1755.2002.00491.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Despite improvements in immunosuppressive protocols and patient care, kidney allografts continue to fail. We studied causes of graft loss for primary kidney transplants in the 1990s to determine major causes and potential interventions. Methods. Causes of graft loss were reviewed for 1467 primary kidney transplants done at our institution between January 1, 1990, and December 31, 1999. Graft loss for that entire population was studied and then the causes of loss selectively examined at <1 year, 1 to 5 years, and>5 years post-transplant. Finally, causes of loss in the 1990s versus the 1980s were compared. Results. Five major causes of graft loss were noted in the 1990s: thrombosis, acute rejection (either alone or combined with delayed graft function or infection), chronic rejection, death with function, and noncompliance. In the first year post-transplant, thrombosis (25%) and death with function (41%) were the major causes of graft loss. After the first year, chronic rejection and death with function predominated. For recipients dying with graft function, cardiovascular disease was the major cause of death. Conclusions. This study identified the five major causes of kidney graft loss in the 1990s. Different interventions are required to decrease loss from each of these causes. Future research needs to be directed at such interventions.
引用
收藏
页码:704 / 714
页数:11
相关论文
共 70 条
[1]   RISK-FACTORS FOR CHRONIC REJECTION IN RENAL-ALLOGRAFT RECIPIENTS [J].
ALMOND, PS ;
MATAS, A ;
GILLINGHAM, K ;
DUNN, DL ;
PAYNE, WD ;
GORES, P ;
GRUESSNER, R ;
NAJARIAN, JS ;
FERGUSON ;
PAUL ;
SCHAFFER .
TRANSPLANTATION, 1993, 55 (04) :752-757
[2]   Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients [J].
Åsberg, A ;
Midtvedt, K ;
Vassbotn, T ;
Hartmann, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) :1465-1470
[3]  
Bakir N, 1996, NEPHROL DIAL TRANSPL, V11, P140
[4]   EARLY VERSUS LATE ACUTE RENAL-ALLOGRAFT REJECTION - IMPACT ON CHRONIC REJECTION [J].
BASADONNA, GP ;
MATAS, AJ ;
GILLINGHAM, KJ ;
PAYNE, WD ;
DUNN, DL ;
SUTHERLAND, DER ;
GORES, PF ;
GRUESSNER, RWG ;
NAJARIAN, JS .
TRANSPLANTATION, 1993, 55 (05) :993-995
[5]   RENAL-TRANSPLANTATION [J].
BENEDETTI, E ;
HAKIM, NS ;
PEREZ, EM ;
MATAS, AJ .
ACADEMIC RADIOLOGY, 1995, 2 (02) :159-166
[6]  
BRENNER BM, 1992, J AM SOC NEPHROL, V3, P162
[7]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[8]   Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension [J].
Calviño, J ;
Lens, XM ;
Romero, R ;
Sánchez-Guisande, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (01) :82-86
[9]  
Cecka J M, 1998, Clin Transpl, P1
[10]   Antigen-independent determinants of cadaveric kidney transplant failure [J].
Chertow, GM ;
Milford, EL ;
Mackenzie, HS ;
Brenner, BM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (21) :1732-1736